Dr. Paul Chang

Senior Advisor - Healthcare Quality Management and Improvement, Accreditation and Governance

Dr. Paul Chang is an accomplished healthcare executive with more than 20 years experience in Global healthcare, business development, and hospital administration and a well-known expert in healthcare quality, accreditation, data management . Most recently, he was Group Head, Medical and Quality for IHH Healthcare, the world’s largest listed hospital operator where he oversaw Medical Affairs, Quality, Risk Management and Quality Improvement issues for the group’s 80 hospitals located in 7 countries in Asia and Europe. In his role, he oversaw implementation of group’s COVID-19 medical management response and treatment protocols including PPE use, management of COVID cases and rollout of COVID-19 vaccinations, strengthened the group’s clinical governance framework by working collaboratively with the group’s International Clinical Governance.

Advisory Council and IHH Board Risk Management Committees and making the group’s Board level Risk Management and Clinical Quality indicators more robust. He also rolled out implementation of clinical pathways such as Total Knee Replacement surgery among the group hospitals, reducing patient length of stay by 50% while improving clinical outcomes and led 10 group hospitals undergoing JCI hospital accreditation surveys towards success.

Prior to that, Dr Chang was Vice President, Accreditation, Standards and Measurement at Joint Commission International (JCI), a global, knowledge-based not-for-profit organization that provides innovative solutions designed to help health care organizations improve patient safety and quality. During his tenure, while the number of customers grew by 30%, revenue grew by 70% and bottom-line improved by 200%.. He also established international accreditation branch office (WOFE) in China with 10 employees within 2 years, completely revamped the JCI Surveyor Training Program to focus more on value-added delivery skills and developed a brand new business line (‘JCI Journey’) focused on engaging customers not yet ready for international healthcare accreditation.

Dr Chang served as JCI’s Asia-Pacific Office Managing Director from 2007 to 2013. While in the Asia-Pacific region, Dr. Chang collaborated with regional ministries of health, governmental and nongovernmental agencies, hospitals, laboratories, and various health care organizations to develop ways to improve health outcomes and patient safety. During his tenure, JCI’s Asia business grew by approximately 500%.

Before joining JCI, Dr Chang had clinical postings in various Sigapore public hospitals. Later, at the Singapore Ministry of Health, he had roles in clinical quality monitoring, setting of professional practice standards for physicians and management of new health services. From 2004, Dr. Chang had oversight of clinical quality, risk management, quality improvement, and hospital licensing and JCI accreditation at Changi General Hospital, an 800-bed Singaporean public hospital. He was also part of the management team that led the hospital to achieve JCI accreditation in 2005 and JCI disease-specific certification in two cardiology programs (Acute Myocardial Infarction and Heart Failure) in 2007.

Dr Chang earned his medical degree (MBBS) and his Master in Public Health (MPH) from the National University of Singapore (NUS). He has a Master in Business Administration (MBA) from both the University of California Los Angeles (UCLA) and the National University of Singapore. He is a Certified Professional in Healthcare Quality (CPHQ), a Fellow of the American College of Healthcare Executives (FACHE), and a part-time surveyor for the International Society for Quality (ISQua).

Areas of Expertise

Industry Expertise

Former Employers